NasdaqGS:PGNYHealthcare
Is Progyny (PGNY) Mispriced After Recent Share Price Weakness And DCF Upside Potential
If you are wondering whether Progyny's current share price reflects its true worth, this article walks through what the numbers are really saying about the stock.
After closing at US$21.65, the shares have seen recent pressure, with returns of a 10.6% decline over 7 days, 19.8% decline over 30 days, 15.9% decline year to date, 3.1% decline over 1 year, 32.9% decline over 3 years, and 57.0% decline over 5 years.
These moves come against a backdrop of ongoing interest in fertility benefits and...